Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News VentriPoint Diagnostics Ltd VPTDF


Primary Symbol: V.VPT

Healthcare Medical Devices
Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and... see more

Recent & Breaking News (TSXV:VPT)

Ventripoint Announces Closing of Second Tranche of Non-Brokered Convertible Debenture Private Placement and the Extension of the Offering

TheNewsWire July 2, 2024

Ventripoint Announces Extension of Non-Brokered Convertible Debenture Private Placement

TheNewsWire June 27, 2024

Ventripoint to Present its AI-enhanced Cardiac Ultrasound Technology to B.C. and Canadian Health Care Leaders at The Data Effect

TheNewsWire June 24, 2024

Ventripoint Welcomes Matt Dobson as Marketing Director to Guide Market Development and Product Management

TheNewsWire June 13, 2024

Ventripoint Diagnostics Announces Shareholder Update and Teleconference

TheNewsWire June 11, 2024

Ventripoint Applies for Extension of Non-Brokered Convertible Debenture Private Placement

TheNewsWire May 14, 2024

Ventripoint Announces Closing of First Tranche of Non-Brokered Convertible Debenture Private Placement

TheNewsWire May 13, 2024

Ventripoint's Next Generation, AI-powered Heart-scanning Technology Submitted to U.S Food and Drug Administration

TheNewsWire May 6, 2024

Duke University Health Center -- One of America's Top Heart-care Institutions and Innovators -- Purchases Ventripoint's AI Heart-scan Technology

TheNewsWire May 1, 2024

Ventripoint Announces Non-Brokered Convertible Debenture Private Placement

TheNewsWire April 11, 2024

Ventripoint Diagnostics Provides Corporate Update and Announces Conference Call

TheNewsWire March 28, 2024

Enhanced Design Breakthrough Makes Ventripoint's VMS+ Even Simpler to Use

TheNewsWire March 4, 2024

Ventripoint Successfully Showcases A.I.-Powered Heart-Scanning Technology at Prestigious International Cardiology Conferences

TheNewsWire February 20, 2024

Ventripoint Welcomes Bart Hendriks as New Strategic Partnerships Executive to Accelerate European and Global Sales

TheNewsWire February 13, 2024

Ventripoint Announces Changes to The Board of Directors

TheNewsWire February 13, 2024

Ventripoint Begins 2024 with Leadership Change

TheNewsWire February 5, 2024

The Medical University of Vienna's Paediatric Heart Centre Purchases Ventripoint's AI-Powered Heart Imaging System

TheNewsWire February 1, 2024

The 2023 Year in Review

TheNewsWire January 29, 2024

Dr. Luc Mertens, Head of Echocardiography at The Hospital for Sick Children, Joins Ventripoint's Clinical Advisory Board

TheNewsWire January 21, 2024

Ventripoint Whitepaper Distribution:

TheNewsWire January 3, 2024